The Traditional Knowledge Digital Library: How India Protects Its Knowledge Heritage

The Traditional Knowledge Digital Library — TKDL — is one of India's most distinctive contributions to global intellectual property practice. Established in 2001 as a joint initiative of the Council of Scientific and Industrial Research (CSIR) and the Ministry of AYUSH, the TKDL contains over 30 million pages of Indian traditional medicine knowledge — primarily Ayurveda, Unani, Siddha and yoga — in patent-office-readable form across multiple languages. The library has been used by Indian and foreign patent offices to refuse or revoke hundreds of patents on traditional-knowledge-based inventions. The neem and turmeric patent revocations in the 1990s — Indian-initiated proceedings that revoked European and US patents on traditional formulations — were the immediate catalyst for the TKDL's creation.

The neem and turmeric cases — the catalyst

In the 1990s, two patents granted in foreign jurisdictions sparked international controversy:

• Neem patent (US 5,124,349 and EP 0,436,257) — granted on a fungicidal property of neem oil. Indian-initiated opposition proceedings at the European Patent Office revoked the patent in 2000, holding that the claimed invention was already part of Indian traditional knowledge
• Turmeric patent (US 5,401,504) — granted on the wound-healing property of turmeric. The US Patent and Trademark Office revoked the patent following Indian-initiated re-examination, again on traditional-knowledge prior-art grounds

These cases demonstrated both the vulnerability of Indian traditional knowledge to inappropriate foreign patenting AND the effectiveness of organised prior-art evidence in challenging such patents. The TKDL was conceived as a systematic solution.

India catalogued thousands of years of knowledge in a format the patent offices could read. Foreign patents on traditional formulations stopped getting granted.

What the TKDL contains

The library covers:

• Ayurveda — formulations from classical Ayurvedic texts (Charaka Samhita, Sushruta Samhita, Ashtanga Hridaya, Madhava Nidana and dozens of others)
• Unani — formulations from classical Unani medical texts
• Siddha — formulations from Tamil Siddha medical tradition
• Yoga — postures and breathing techniques from classical and modern texts
• Naturopathy and folk medicine — selected traditional therapeutic practices

Each entry is structured for patent-office search: it includes the formulation/practice, the source text, the therapeutic claims, the relevant search keywords, and translations into English, German, French, Spanish, and Japanese — the languages most patent offices examine in.

How patent offices use the TKDL

The TKDL is accessible to patent offices that have signed access agreements with CSIR. Major patent offices with TKDL access include:

• European Patent Office
• United States Patent and Trademark Office
• Japan Patent Office
• Indian Patent Office
• UK Intellectual Property Office
• Canadian Intellectual Property Office
• Australian patent office
• German Patent and Trade Mark Office

Examiners at these offices can search the TKDL for prior art on traditional-knowledge-based applications. Documented results: over 200 patent applications have been refused, withdrawn or amended worldwide based on TKDL evidence as of recent reports, with hundreds more under prior-art assessment.

The Section 3(p) connection

Indian patent applications interact with the TKDL through Section 3(p) of the Patents Act, which excludes 'an invention which, in effect, is traditional knowledge or which is an aggregation or duplication of known properties of traditionally known component or components'. Indian examiners specifically check applications in pharma, biotech and Ayurveda-adjacent fields against the TKDL.

For Indian applicants in these sectors — including the substantial Ayurveda and herbal-formulation industry — the practical implication: filings that claim novel formulations of traditionally-known components must demonstrate genuine innovation beyond the traditional combination. Indian Ayurveda companies navigate this through structured patent strategy focused on novel delivery systems, non-traditional active ingredients, and patentable manufacturing processes.

The Biological Diversity Act overlay

The Biological Diversity Act 2002 adds a complementary protection layer. Section 6 requires applicants for IP rights based on Indian biological resources or traditional knowledge to obtain prior approval from the National Biodiversity Authority. The approval process examines whether the resource or knowledge originates from a community entitled to benefit-sharing, what compensation arrangements are appropriate, and whether the patent application properly discloses the source.

Failure to obtain NBA approval is criminal under Section 55 of the Act. The framework is designed to prevent unauthorised commercialisation of Indian biological resources and traditional knowledge — and to ensure benefit-sharing flows to the originating communities.

International discussions

The TKDL has influenced international discussions on traditional knowledge protection:

• WIPO Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore — Indian participation has been substantial, with the TKDL model presented as a workable framework
• Nagoya Protocol on Access and Benefit-Sharing — India is a party; the TKDL and Biological Diversity Act framework collectively give effect to Nagoya principles in the Indian context
• Bilateral access agreements — the TKDL access agreements have been a model for similar traditional-knowledge databases by other countries (China, South Korea, indigenous-community projects in Latin America)

What this means for Indian inventors

For Indian inventors and companies operating in Ayurveda, traditional medicine, herbal formulations and biological-resource-based industries:

• The TKDL is a prior-art reservoir that will be searched on any filing in these areas
• Novel formulations must demonstrate genuine innovation beyond traditional combinations
• Biological Diversity Act approval is required before filing where Indian biological resources are involved
• Source disclosure in patent applications is mandatory
• The IP strategy should focus on areas of genuine novelty — delivery systems, non-traditional combinations, manufacturing processes, isolated active compounds with enhanced efficacy

The takeaway

The Traditional Knowledge Digital Library is one of India's most successful IP-policy interventions. It protects Indian traditional knowledge against inappropriate patenting globally, supports Section 3(p) examination domestically, and gives the Indian Ayurveda and herbal-formulation industries a structured framework within which to operate. For inventors in these fields, the TKDL is not an obstacle to patentability — it is a defined prior-art landscape that channels innovation toward genuinely novel contributions beyond traditional knowledge. IPForte's patentability search practice includes TKDL screening on every pharma, Ayurveda and biotech application.